David Vallerand
Overview
Explore the profile of David Vallerand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bettoun A, Joffre C, Zago G, Surdez D, Vallerand D, Gundogdu R, et al.
Oncotarget
. 2018 Jun;
9(32):22870.
PMID: 29854321
[This corrects the article DOI: 10.18632/oncotarget.9875.].
2.
Vallerand D, Massonnet G, Kebir F, Gentien D, Maciorowski Z, De La Grange P, et al.
PLoS One
. 2016 Jul;
11(7):e0157670.
PMID: 27388901
Drug discovery efforts have focused on the tumor microenvironment in recent years. However, few studies have characterized the stroma component in patient-derived xenografts (PDXs) and genetically engineered mouse models (GEMs)....
3.
Bettoun A, Joffre C, Zago G, Surdez D, Vallerand D, Gundogdu R, et al.
Oncotarget
. 2016 Jun;
7(28):44142-44160.
PMID: 27283898
Oncogenic Ras signalling occurs frequently in many human cancers. However, no effective targeted therapies are currently available to treat patients suffering from Ras-driven tumours. Therefore, it is imperative to identify...
4.
Couderc C, Boin A, Fuhrmann L, Vincent-Salomon A, Mandati V, Kieffer Y, et al.
Neoplasia
. 2016 Jan;
18(1):10-24.
PMID: 26806348
The Hippo signaling network is a key regulator of cell fate. In the recent years, it was shown that its implication in cancer goes well beyond the sole role of...
5.
le Jan S, Plee J, Vallerand D, Dupont A, Delanez E, Durlach A, et al.
J Invest Dermatol
. 2014 Jun;
134(12):2908-2917.
PMID: 24945093
Bullous pemphigoid (BP) is an autoimmune skin disease characterized by the binding of autoantibodies to components of the hemidesmosome structure, resulting in an inflammatory response and subepidermal blister formation. To...
6.
Bieche I, Vacher S, Vallerand D, Richon S, Hatem R, de Plater L, et al.
BMC Cancer
. 2014 Mar;
14:178.
PMID: 24625025
Background: Tumor endothelial transdifferentiation and VEGFR1/2 expression by cancer cells have been reported in glioblastoma but remain poorly documented for many other cancer types. Methods: To characterize vasculature of patient-derived...
7.
Nemati F, de Montrion C, Lang G, Kraus-Berthier L, Carita G, Sastre-Garau X, et al.
PLoS One
. 2014 Jan;
9(1):e80836.
PMID: 24454684
Purpose: Uveal melanoma (UM) is associated with a high risk of metastases and lack of efficient therapies. Reduced capacity for apoptosis induction by chemotherapies is one obstacle to efficient treatments....
8.
Arrouss I, Nemati F, Roncal F, Wislez M, Dorgham K, Vallerand D, et al.
PLoS One
. 2013 May;
8(4):e60816.
PMID: 23637769
Purpose: PP2A is a serine/threonine phosphatase critical to physiological processes, including apoptosis. Cell penetrating peptides are molecules that can translocate into cells without causing membrane damage. Our goal was to...
9.
Petit V, Massonnet G, Maciorowski Z, Touhami J, Thuleau A, Nemati F, et al.
Lab Invest
. 2013 Mar;
93(5):611-21.
PMID: 23459372
Metabolic adaptations and changes in the expression of nutrient transporters are known to accompany tumorigenic processes. Nevertheless, in the context of solid tumors, studies of metabolism are hindered by a...